NCT06561685 2026-04-20
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Phase 1 Recruiting
Eli Lilly and Company
Asan Medical Center
Hoffmann-La Roche
AstraZeneca
AstraZeneca
Memorial Sloan Kettering Cancer Center